CF
CLB icon

C.T. Fitzpatrick’s Core Laboratories CLB Stock Holding History

C.T. Fitzpatrick’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-171,164
Closed -$17.1M – 71
2015
Q3 		$17.1M Buy
+171,164
New +$18.6M 0.17% 55

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

C.T. Fitzpatrick's CLB Position: Q4 2015 in Review

C.T. Fitzpatrick sold out of Core Laboratories (CLB) in Q4 2015, closing a stake of 171,164 shares — an estimated $17.1M sold.

C.T. Fitzpatrick first reported a position in CLB in Q3 2015 and held it in 1 quarter. The position peaked at $17.1M in Q3 2015. 372 funds tracked by Wall St. Rank hold CLB as of Q4 2015.

  • C.T. Fitzpatrick reported no remaining Core Laboratories position as of Q4 2015 after selling out during the quarter.
  • C.T. Fitzpatrick sold 171,164 Core Laboratories shares in Q4 2015, an estimated $17.1M.
  • C.T. Fitzpatrick first reported a position in Core Laboratories in Q3 2015 and held it in 1 quarter.
  • C.T. Fitzpatrick's Core Laboratories position peaked at $17.1M in Q3 2015.
  • 372 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2015.

Based on Vulcan Value Partners's 13F filing for Q4 2015, filed 16 Feb 2016.